论文部分内容阅读
目的观察胺碘酮治疗急性心肌梗死后室性心律失常的临床效果。方法资料选取本院2015年6月—2016年6月收治的急性心肌梗死后室性心律失常患者150例,按照不同的治疗方法分为两组,即研究组与对照组,每组75例;其中研究组患者予胺碘酮治疗,对照组患者予常规治疗并服用托拉塞米;观察并记录两组临床疗效、相关性指标和不良反应发生率情况。结果研究组患者的临床总有效率显著优于对照组,比较差异明显具统计学意义(P<0.05);研究组PVC、PAC次数以及HR次数显著高于对照组,比较具统计学意义(P<0.05),研究组SBP、DBP监测值与对照组相比略存在差异,但二者比较无统计学意义(P>0.05);研究组出现不良反应5例(6.67%),显著低于对照组的13例(17.33%),比较差异明显具统计学意义(P<0.05)。结论急性心肌梗死后室性心律失常行胺碘酮治疗临床疗效显著,具有实际应用价值。
Objective To observe the clinical effect of amiodarone on ventricular arrhythmia after acute myocardial infarction. Method data 150 cases of ventricular arrhythmia after acute myocardial infarction admitted to our hospital from June 2015 to June 2016 were divided into two groups according to different treatment methods, namely study group and control group, with 75 cases in each group. Patients in the study group were treated with amiodarone, while patients in the control group were given conventional treatment and taking torsemide. The clinical efficacy, the related indicators and the incidence of adverse reactions in the two groups were observed and recorded. Results The clinical total effective rate of the study group was significantly better than that of the control group, the difference was statistically significant (P <0.05); the number of PVC, PAC and HR in the study group was significantly higher than that in the control group (P <0.05). There was a slight difference between the two groups in the SBP and DBP levels in the study group (P> 0.05). There were 5 (6.67%) adverse reactions in the study group, which were significantly lower than those in the control group There were 13 cases (17.33%) in the group, the difference was statistically significant (P <0.05). Conclusion Amiodarone is effective in treating ventricular arrhythmia after acute myocardial infarction and has practical value.